Multi-Dose Use: Built-in antimicrobial preservative allows safe use for up to 28 days after first puncture
Given the significant benefits for patients with CKD, the FDA approved a new indication for semaglutideto reduce the risk of estimated glomerular filtration rate decline, end-stage kidney disease, and cardiovascular death in patients with T2D and CKD
36 The SGLT-2i has more robust data supporting kidney protection (beyond albuminuria) including dialysis, transplantation, renal death, and progression to end-stage renal disease
Book a consultation today at our Beverly, MA medspa to explore whether semaglutide is right for you
The landscape of medical knowledge about these common drugs continues to evolve, with new research revealing complexities in how they work and new safety considerations emerging from ongoing studies and regulatory reviews
Beyond muscles: the untapped potential of creatine